Avid Bioservices Analysis

CDMODelisted Stock  USD 12.49  0.00  0.00%   
Avid Bioservices is overvalued with Real Value of 10.3 and Hype Value of 12.49. The main objective of Avid Bioservices delisted stock analysis is to determine its intrinsic value, which is an estimate of what Avid Bioservices is worth, separate from its market price. There are two main types of Avid Bioservices' stock analysis: fundamental analysis and technical analysis.
The Avid Bioservices stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Avid Bioservices is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Avid Stock trading window is adjusted to America/New York timezone.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Avid Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.41. Avid Bioservices last dividend was issued on the 10th of July 2017. The entity had 1:7 split on the 10th of July 2017. Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people. For more info on Avid Bioservices please contact the company at 714 508 6100 or go to https://www.avidbio.com.

Avid Bioservices Investment Alerts

Avid Bioservices is not yet fully synchronised with the market data
Avid Bioservices has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 139.91 M. Net Loss for the year was (140.75 M) with profit before overhead, payroll, taxes, and interest of 8.93 M.
Over 99.0% of the company shares are held by institutions such as insurance companies

Avid Bioservices Upcoming and Recent Events

Earnings reports are used by Avid Bioservices to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
11th of March 2024
Upcoming Quarterly Report
View
19th of June 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
19th of June 2024
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
30th of April 2023
Last Financial Announcement
View

Avid Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 798.9 M.

Avid Profitablity

The company has Profit Margin (PM) of (1.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06.

Avid Bioservices Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avid Bioservices insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avid Bioservices' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avid Bioservices insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Hancock Richard B over a month ago
Disposition of 20128 shares by Hancock Richard B of Avid Bioservices subject to Rule 16b-3
 
Carleone Joseph over a month ago
Acquisition by Carleone Joseph of 8147 shares of Avid Bioservices subject to Rule 16b-3
 
Green Nicholas Stewart over two months ago
Acquisition by Green Nicholas Stewart of 1755 shares of Avid Bioservices at 6.052 subject to Rule 16b-3
 
Green Nicholas Stewart over two months ago
Disposition of 88236 shares by Green Nicholas Stewart of Avid Bioservices at 12.22 subject to Rule 16b-3
 
Green Nicholas Stewart over two months ago
Acquisition by Green Nicholas Stewart of 119973 shares of Avid Bioservices subject to Rule 16b-3
 
Green Nicholas Stewart over two months ago
Disposition of 51653 shares by Green Nicholas Stewart of Avid Bioservices at 12.2746 subject to Rule 16b-3
 
Green Nicholas Stewart over three months ago
Disposition of 75000 shares by Green Nicholas Stewart of Avid Bioservices at 12.3122 subject to Rule 16b-3
 
Alegria Esther M. over three months ago
Disposition of 26756 shares by Alegria Esther M. of Avid Bioservices subject to Rule 16b-3
 
Ziebell Mark R over six months ago
Acquisition by Ziebell Mark R of 1250 shares of Avid Bioservices subject to Rule 16b-3
 
Matthew Kwietniak over six months ago
Acquisition by Matthew Kwietniak of 1271 shares of Avid Bioservices subject to Rule 16b-3
 
Matthew Kwietniak over six months ago
Disposition of 307 shares by Matthew Kwietniak of Avid Bioservices at 8.36 subject to Rule 16b-3
 
Matthew Kwietniak over six months ago
Disposition of 119 shares by Matthew Kwietniak of Avid Bioservices at 8.05 subject to Rule 16b-3

Avid Bioservices Outstanding Bonds

Avid Bioservices issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avid Bioservices uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avid bonds can be classified according to their maturity, which is the date when Avid Bioservices has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Avid Bioservices Predictive Daily Indicators

Avid Bioservices intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avid Bioservices stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Avid Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avid Bioservices prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avid shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Avid Bioservices. By using and applying Avid Stock analysis, traders can create a robust methodology for identifying Avid entry and exit points for their positions.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Avid Bioservices to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Avid Stock

If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing